| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-HER2 therapy for metastatic breast cancer in low- and middle-income countries: bridging the gap between clinical trials and real life
|
Soares, Leonardo Ribeiro
|
|
|
181 |
3 |
p. 693-694
|
artikel
|
| 2 |
A prospective cohort study to analyze the interaction of tumor-to-breast volume in breast conservation therapy versus mastectomy with reconstruction
|
Dolen, Utku
|
|
|
181 |
3 |
p. 611-621
|
artikel
|
| 3 |
Assessing breast lymphoedema following breast cancer treatment using indocyanine green lymphography
|
Heydon-White, Asha
|
|
|
181 |
3 |
p. 635-644
|
artikel
|
| 4 |
Breast sensibility in bilateral autologous breast reconstruction with unilateral sensory nerve coaptation
|
Bijkerk, Ennie
|
|
|
181 |
3 |
p. 599-610
|
artikel
|
| 5 |
Chemotherapy use near the end-of-life in patients with metastatic breast cancer
|
Edman Kessler, Luisa
|
|
|
181 |
3 |
p. 645-651
|
artikel
|
| 6 |
Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy
|
O’Toole, Sharon A.
|
|
|
181 |
3 |
p. 571-580
|
artikel
|
| 7 |
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015
|
O’Donnell, Peter H.
|
|
|
181 |
3 |
p. 623-633
|
artikel
|
| 8 |
Diagnostic performance of automated breast ultrasound and handheld ultrasound in women with dense breasts
|
Jia, Mengmeng
|
|
|
181 |
3 |
p. 589-597
|
artikel
|
| 9 |
Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review
|
Niño de Guzmán, Ena
|
|
|
181 |
3 |
p. 499-518
|
artikel
|
| 10 |
HER2 intratumoral heterogeneity is independently associated with distal metastasis and overall survival in HER2-positive breast carcinomas
|
Shen, Tiansheng
|
|
|
181 |
3 |
p. 519-527
|
artikel
|
| 11 |
Is there any association between absolute lymphocyte count and increased tumor-infiltrating lymphocytes in metastatic sites in advanced breast cancer patients who get benefit from eribulin treatment?
|
Altundag, Kadri
|
|
|
181 |
3 |
p. 691
|
artikel
|
| 12 |
Medical costs associated with metastatic breast cancer in younger, midlife, and older women
|
Trogdon, Justin G.
|
|
|
181 |
3 |
p. 653-665
|
artikel
|
| 13 |
MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients
|
Hunt, Brian G.
|
|
|
181 |
3 |
p. 529-540
|
artikel
|
| 14 |
Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer
|
Aljohani, Abrar I.
|
|
|
181 |
3 |
p. 541-551
|
artikel
|
| 15 |
PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies
|
Stovgaard, E. S.
|
|
|
181 |
3 |
p. 553-560
|
artikel
|
| 16 |
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors
|
Wang, Chun
|
|
|
181 |
3 |
p. 679-689
|
artikel
|
| 17 |
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium
|
Dietz, Jill R.
|
|
|
181 |
3 |
p. 487-497
|
artikel
|
| 18 |
The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers
|
Obdeijn, Inge-Marie
|
|
|
181 |
3 |
p. 581-588
|
artikel
|
| 19 |
Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study
|
Gómez-Acebo, Inés
|
|
|
181 |
3 |
p. 667-678
|
artikel
|
| 20 |
Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study
|
Wang, Ruo-Xi
|
|
|
181 |
3 |
p. 561-570
|
artikel
|
Tijdschrift beschrijving